DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Reiterates Buy on GlycoMimetics, Lowers Price Target to $16

H.C. Wainwright analyst Edward White reiterates GlycoMimetics (NASDAQ:GLYC) with a Buy and lowers the price target from $18 to $16.

Benzinga · 03/02/2020 12:28

H.C. Wainwright analyst Edward White reiterates GlycoMimetics (NASDAQ:GLYC) with a Buy and lowers the price target from $18 to $16.